Search
for
Did you mean Venous Thromboembolism?
Sort by
Research 30 of 1000+
- 52309 Association of venous thromboembolism in patients with alopecia areata
- Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis
- Venous thromboembolism and women's health
- Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Combined hormonal contraception and venous thromboembolism
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Alopecia areata does not increase the risk of venous thromboembolism: an All of Us case-control study
- The acne hormones
- Hormonal contraceptives: pharmacology tailored to women's health
- Endocrine intervention for transsexuals
- Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
- Transgender health and the impact of aging and menopause
- Gender-Affirming Hormone Therapy for Transgender Females
- Is hormonal treatment still an option in acne today?
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Gonadal Suppressive and Cross‐Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
- Contraceptive use in acne
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Balancing Hormones and Skin Health: A Focus on Oral Contraceptives in Dermatology
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Contraceptive implants considered 'safe'
- Update in Hematology and Oncology: Evidence Published in 2010